The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
321 - A patient information brochure will NOT mention the product but will bear the name of the manufacturer. It will be distributed by the rep to the requesting health care professionals. Will this still need PAAB review?
-
A patient piece generated by the manufacturer or its agent requires PAAB review unless both of the following conditions are met: there is no discussion of drug therapy (by product, class, or category) there is no discussion of drug issues (e.g. adherence to medication, potential implications of product ingredients…etc )
